These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22093966)

  • 21. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
    Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
    Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer.
    Pandha H; Sorensen KD; Orntoft TF; Langley S; Hoyer S; Borre M; Morgan R
    BJU Int; 2012 Sep; 110(6 Pt B):E287-92. PubMed ID: 22583908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.
    Stamatiou K; Alevizos A; Karanasiou V; Mariolis A; Mihas C; Papathanasiou M; Bovis K; Sofras F
    Urol Int; 2007; 78(4):313-7. PubMed ID: 17495488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy.
    Salomon G; Köllerman J; Thederan I; Chun FK; Budäus L; Schlomm T; Isbarn H; Heinzer H; Huland H; Graefen M
    Eur Urol; 2008 Dec; 54(6):1354-62. PubMed ID: 18374470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series.
    Nevoux P; Ouzzane A; Ahmed HU; Emberton M; Montironi R; Presti JC; Villers A
    BJU Int; 2012 Aug; 110(4):517-23. PubMed ID: 22192756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer: 1.5 T endo-coil dynamic contrast-enhanced MRI and MR spectroscopy--correlation with prostate biopsy and prostatectomy histopathological data.
    Chabanova E; Balslev I; Logager V; Hansen A; Jakobsen H; Kromann-Andersen B; Norgaard N; Horn T; Thomsen HS
    Eur J Radiol; 2011 Nov; 80(2):292-6. PubMed ID: 20708869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.
    Taverna G; Morandi G; Seveso M; Giusti G; Benetti A; Colombo P; Minuti F; Grizzi F; Graziotti P
    BJU Int; 2011 Dec; 108(11):1723-7. PubMed ID: 21756276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computer-aided (HistoScanning) biopsies versus conventional transrectal ultrasound-guided prostate biopsies: do targeted biopsy schemes improve the cancer detection rate?
    Hamann MF; Hamann C; Schenk E; Al-Najar A; Naumann CM; Jünemann KP
    Urology; 2013 Feb; 81(2):370-5. PubMed ID: 23374806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of routine transition zone biopsies in Japanese men undergoing transrectal ultrasound-guided prostate biopsies.
    Miyake H; Kurahashi T; Muramaki M; Yamanak K; Hara I
    Int J Urol; 2005 Nov; 12(11):964-8. PubMed ID: 16351652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transrectal ultrasound (TRUS) and TRUS-biopsy accuracy in potential candidates for PRIAS active surveillance protocol.
    Lacetera V; Galosi AB; Cantoro U; Catanzariti F; Mazzaferro D; Cantoro D; Quaresima L; Conti A; Raquban R; Montironi R; Muzzonigro G
    Arch Ital Urol Androl; 2012 Dec; 84(4):272-5. PubMed ID: 23427762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel.
    Smeenge M; Barentsz J; Cosgrove D; de la Rosette J; de Reijke T; Eggener S; Frauscher F; Kovacs G; Matin SF; Mischi M; Pinto P; Rastinehad A; Rouviere O; Salomon G; Polascik T; Walz J; Wijkstra H; Marberger M
    BJU Int; 2012 Oct; 110(7):942-8. PubMed ID: 22462566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transrectal ultrasound and core biopsies for the diagnosis of prostate cancer. A study of pretreatment investigation strategy for patients with suspected prostate cancer.
    Norberg M
    Acta Radiol Suppl; 1994; 393():1-21. PubMed ID: 8184698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transrectal ultrasound versus magnetic resonance imaging in the estimation of prostate volume as compared with radical prostatectomy specimens.
    Lee JS; Chung BH
    Urol Int; 2007; 78(4):323-7. PubMed ID: 17495490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion.
    Hadaschik BA; Kuru TH; Tulea C; Rieker P; Popeneciu IV; Simpfendörfer T; Huber J; Zogal P; Teber D; Pahernik S; Roethke M; Zamecnik P; Roth W; Sakas G; Schlemmer HP; Hohenfellner M
    J Urol; 2011 Dec; 186(6):2214-20. PubMed ID: 22014798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of 111in-capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland.
    Mouraviev V; Madden JF; Broadwater G; Mayes JM; Burchette JL; Schneider F; Smith J; Tsivian M; Wong T; Polascik TJ
    J Urol; 2009 Sep; 182(3):938-47. PubMed ID: 19616259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.
    Wysock JS; Rosenkrantz AB; Huang WC; Stifelman MD; Lepor H; Deng FM; Melamed J; Taneja SS
    Eur Urol; 2014 Aug; 66(2):343-51. PubMed ID: 24262102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using imaging biomarkers to improve the planning of radical prostatectomies.
    Faure Walker NA; Nir D; Simmons L; Agrawal S; Chung C; Leminski A; Rashid T; Shamsuddin A; Winkler M
    Urol Oncol; 2015 Jan; 33(1):17.e19-17.e25. PubMed ID: 25443269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of prostatic adenocarcinoma after a negative prostate biopsy.
    Park PC; Mai KT; Roustan Delatour NL; Morash C; Cagiannos I
    BJU Int; 2006 Nov; 98(5):986-8. PubMed ID: 17034600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.